EHWM
BIIB icon

Eads & Heald Wealth Management’s Biogen BIIB Stock Holding History

Eads & Heald Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+1,081
New +$207K 0.11% 138
2021
Q4 		– Sell
-761
Closed -$215K – 147
2021
Q3 		$215K Buy
+761
New +$249K 0.1% 139
2019
Q1 		– Sell
-805
Closed -$242K – 127
2018
Q4 		$242K Hold
805
– – 0.16% 118
2018
Q3 		$284K Sell
805
-30
-4% -$10.3K 0.16% 117
2018
Q2 		$242K Sell
835
-33
-4% -$9.28K 0.15% 121
2018
Q1 		$238K Buy
868
+78
+10% +$24.2K 0.15% 119
2017
Q4 		$252K Sell
790
-90
-10% -$28.9K 0.15% 118
2017
Q3 		$276K Sell
880
-136
-13% -$40.3K 0.17% 117
2017
Q2 		$276K Sell
1,016
-165
-14% -$43.6K 0.18% 116
2017
Q1 		$323K Sell
1,181
-30
-2% -$8.48K 0.21% 114
2016
Q4 		$343K Sell
1,211
-274
-18% -$81.2K 0.23% 115
2016
Q3 		$465K Sell
1,485
-300
-17% -$88.9K 0.32% 106
2016
Q2 		$432K Sell
1,785
-270
-13% -$71.2K 0.3% 107
2016
Q1 		$535K Buy
2,055
+65
+3% +$17.2K 0.37% 102
2015
Q4 		$610K Sell
1,990
-230
-10% -$66.1K 0.42% 95
2015
Q3 		$648K Buy
2,220
+15
+0.7% +$4.95K 0.46% 89
2015
Q2 		$891K Buy
2,205
+387
+21% +$155K 0.59% 78
2015
Q1 		$768K Sell
1,818
-149
-8% -$58.7K 0.49% 84
2014
Q4 		$668K Sell
1,967
-35
-2% -$11.3K 0.42% 97
2014
Q3 		$662K Buy
2,002
+480
+32% +$158K 0.45% 89
2014
Q2 		$480K Buy
1,522
+110
+8% +$33.1K 0.32% 100
2014
Q1 		$432K Buy
1,412
+209
+17% +$66.3K 0.28% 101
2013
Q4 		$336K Buy
1,203
+260
+28% +$67.2K 0.22% 106
2013
Q3 		$227K Sell
943
-285
-23% -$63.8K 0.16% 111
2013
Q2 		$264K Buy
+1,228
New +$262K 0.19% 106

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eads & Heald Wealth Management's BIIB Position: Q2 2026 in Review

Eads & Heald Wealth Management opened a new position in Biogen (BIIB) in Q2 2026: 1,081 shares worth $234K. The stake represents 0.11% of the portfolio and ranks #138 among its holdings. This is a return to the name: Eads & Heald Wealth Management previously reported a position in BIIB as recently as Q3 2021.

Eads & Heald Wealth Management first reported a position in BIIB in Q2 2013 and has held it in 25 quarters since. The position peaked at $891K in Q2 2015. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Eads & Heald Wealth Management held 1,081 shares of Biogen worth $234K as of Q2 2026.
  • Biogen was a new Eads & Heald Wealth Management position in Q2 2026.
  • Biogen made up 0.11% of Eads & Heald Wealth Management's portfolio in Q2 2026, its #138 holding.
  • Eads & Heald Wealth Management first reported a position in Biogen in Q2 2013 and has held it in 25 quarters since.
  • Eads & Heald Wealth Management's Biogen position peaked at $891K in Q2 2015.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.